Albemarle Expands API Production Site

Albemarle says it has expanded and upgraded its U.S. FDA-approved multi-product active pharmaceutical ingredient (API) manufacturing facility at South Haven, MI. Production using the new expanded capacity commenced on June 1, 2012. The expansion is the latest in a series of projects at the South Haven site to increase capabilities and production throughput, meeting the increasing demand for both generic API products and custom manufacturing service portfolios, Albemarle says.  In the past two years, the number of custom API projects has more than doubled at...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers